PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Albireo Pharma, Inc. (ALBO)

Equity · Currency in USD · Last updated Dec 2, 2023
SummaryFinancials

Company Info

ISINUS01345P1066
CUSIP01345P106
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$37.13B
EPS$0.91
PE Ratio82.96
PEG Ratio1.99
Revenue (TTM)$9.27B
Gross Profit (TTM)$4.81B
EBITDA (TTM)$2.11B
Year Range$63.58 - $86.20
Target Price$88.47
Short %1.52%
Short Ratio3.02

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Albireo Pharma, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALBO

Albireo Pharma, Inc.

Return


PeriodReturnBenchmark
Year-To-DateN/A19.67%
1 monthN/A8.42%
6 monthsN/A7.29%
1 yearN/A12.71%
5 years (annualized)N/A10.75%
10 years (annualized)N/A9.87%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-0.25%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Albireo Pharma, Inc. (ALBO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALBO
Albireo Pharma, Inc.
N/A
^GSPC
S&P 500
0.91

Sharpe Ratio


Rolling 12-month Sharpe Ratio
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

Dividend History


Albireo Pharma, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Albireo Pharma, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Albireo Pharma, Inc. was 99.77%, occurring on Dec 17, 2015. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.77%Jan 10, 20081999Dec 17, 2015
-32.88%Jun 21, 2007103Nov 14, 200726Dec 21, 2007129
-5.71%Jun 4, 20075Jun 8, 20075Jun 15, 200710
-3.02%May 15, 20074May 18, 20074May 24, 20078
-2.91%Dec 28, 20073Jan 2, 20083Jan 7, 20086

Volatility Chart

The current Albireo Pharma, Inc. volatility is 2.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)